A 28-year-old male from rural Maharashtra presents to the emergency department with a 10-day history of fever, headache, and progressive neurological deterioration. He reports a dog bite on his left hand 6 weeks ago, which he did not seek medical attention for. On examination, he is febrile (38.5°C), agitated, and exhibits hydrophobia—he experiences severe throat spasms when attempting to drink water. CSF analysis shows lymphocytic pleocytosis with normal glucose and protein levels. What is the most appropriate immediate intervention?

Explanation

## Clinical Diagnosis: Rabies Encephalitis **Key Point:** This patient presents with classic rabies encephalitis—hydrophobia (pharyngeal spasms on attempting to drink water), fever, agitation, and progressive neurological decline following an untreated dog bite 6 weeks prior. The incubation period (2 weeks to several months) and symptom constellation are pathognomonic for clinical rabies. ## Why Supportive/Palliative Care is the Answer **High-Yield:** Once clinical rabies develops (symptomatic phase), the disease is **almost universally fatal (~99.9% mortality)**. There is **no proven curative treatment** for established clinical rabies. The standard of care in this setting is **supportive care with palliative management**, focusing on relief of suffering (sedation for agitation/spasms, anxiolytics, analgesics) and comfort measures. **Clinical Pearl (Milwaukee Protocol):** The Milwaukee Protocol (induced coma + high-dose antivirals + hypothermia) was first used in 2004 and achieved survival in a small number of patients. However, subsequent systematic reviews and the WHO have concluded that: - The overall success rate is extremely low (~3–8% at best) - Most documented survivors had received **prior post-exposure prophylaxis (PEP)** before symptom onset, suggesting residual immune priming - The protocol has **not been validated** in resource-limited settings and is **not considered standard of care** globally - Multiple attempts to replicate the protocol have failed, and it remains **experimental**, not a recommended first-line intervention Per **Harrison's Principles of Internal Medicine** and **WHO rabies guidelines**: once symptomatic rabies is established, management is palliative. The Milwaukee Protocol is investigational and should not be presented as the definitive "most appropriate immediate intervention." ## Why Other Options Are Incorrect - **Option A (Intrathecal ribavirin):** No evidence of efficacy; not recommended in any guideline. - **Option B (Milwaukee Protocol):** Experimental, not standard of care; most attempts have failed; not appropriate to label as the "most appropriate immediate intervention." - **Option D (IV acyclovir + dexamethasone):** Appropriate for HSV encephalitis (which this is not); acyclovir has no activity against rabies virus; dexamethasone may worsen outcomes in viral encephalitis. ## Distinguishing Rabies from HSV Encephalitis | Feature | Rabies | HSV Encephalitis | |---|---|---| | Hydrophobia | Present | Absent | | Animal bite history | Present | Absent | | CSF glucose | Normal | Normal/low | | Treatment | Palliative | IV Acyclovir | **Mnemonic:** **RABIES = Really Almost Basically Inevitably Ends in death (once symptomatic)** — emphasizing the critical importance of **pre-exposure prophylaxis and post-exposure prophylaxis (PEP)** before symptom onset. **Reference:** Harrison's Principles of Internal Medicine, 21st ed.; WHO Expert Consultation on Rabies, 3rd Report (2018).